Literature DB >> 7715832

Intrathecal gamma-aminobutyric acidB (GABAB) receptor antagonist CGP 35348 induces hypersensitivity to mechanical stimuli in the rat.

J X Hao1, X J Xu, Z Wiesenfeld-Hallin.   

Abstract

Intrathecal (i.t.) administration of the gamma-aminobutyric acidB (GABAB) receptor antagonist CGP 35348 in the rat resulted in a dose-dependent pain-like response (vocalization) to innocuous mechanical stimuli and touch/pressure). The effect was maximally evoked by stimulation applied to a dermatome corresponding to the spinal levels of the i.t. injections. The paw withdrawal threshold to pressure was also moderately decreased after i.t. CGP 35348. In contrast, i.t. CGP 35348 had no effect on the hot plate test. It is suggested that the input of low threshold afferents innervating mechanoceptors is tonically inhibited by the GABA system through B-type receptors, and blockade of this system results in mechanical hypersensitivity that is similar to mechanical allodynia (painful response to innocuous stimulation) observed in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7715832     DOI: 10.1016/0304-3940(94)90821-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Are spinal GABAergic elements related to the manifestation of neuropathic pain in rat?

Authors:  Jaehee Lee; Seung Keun Back; Eun Jeong Lim; Gyu Chong Cho; Myung Ah Kim; Hee Jin Kim; Min Hee Lee; Heung Sik Na
Journal:  Korean J Physiol Pharmacol       Date:  2010-04-30       Impact factor: 2.016

2.  Spinal sensory projection neuron responses to spinal cord stimulation are mediated by circuits beyond gate control.

Authors:  Tianhe C Zhang; John J Janik; Ryan V Peters; Gang Chen; Ru-Rong Ji; Warren M Grill
Journal:  J Neurophysiol       Date:  2015-05-13       Impact factor: 2.714

3.  Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

Authors:  Shuanglin Hao; Marina Mata; Darren Wolfe; Shaohua Huang; Joseph C Glorioso; David J Fink
Journal:  Ann Neurol       Date:  2005-06       Impact factor: 10.422

4.  Spinal nerve ligation decreases γ-aminobutyric acidB receptors on specific populations of immunohistochemically identified neurons in L5 dorsal root ganglion of the rat.

Authors:  Mitchell P Engle; Michelle A Merrill; Blanca Marquez De Prado; Donna L Hammond
Journal:  J Comp Neurol       Date:  2012-06-01       Impact factor: 3.215

5.  Intraspinal transplantation of GABAergic neural progenitors attenuates neuropathic pain in rats: a pharmacologic and neurophysiological evaluation.

Authors:  Stanislava Jergova; Ian D Hentall; Shyam Gajavelli; Mathew S Varghese; Jacqueline Sagen
Journal:  Exp Neurol       Date:  2011-12-13       Impact factor: 5.330

6.  Spinal nerve ligation does not alter the expression or function of GABA(B) receptors in spinal cord and dorsal root ganglia of the rat.

Authors:  M P Engle; M Gassman; K T Sykes; B Bettler; D L Hammond
Journal:  Neuroscience       Date:  2006-01-20       Impact factor: 3.590

7.  Midazolam administration reverses thermal hyperalgesia and prevents gamma-aminobutyric acid transporter loss in a rodent model of neuropathic pain.

Authors:  Andre Shih; Vjekoslav Miletic; Gordana Miletic; Lesley J Smith
Journal:  Anesth Analg       Date:  2008-04       Impact factor: 5.108

8.  Effect of intrathecal glycine and related amino acids on the allodynia and hyperalgesic action of strychnine or bicuculline in mice.

Authors:  Eui Sung Lim; Il Ok Lee
Journal:  Korean J Anesthesiol       Date:  2010-01-31

9.  Selected Gamma Aminobutyric Acid (GABA) Esters may Provide Analgesia for Some Central Pain Conditions.

Authors:  Joel S Goldberg
Journal:  Perspect Medicin Chem       Date:  2010-08-03

10.  Loss of central inhibition: implications for behavioral hypersensitivity after contusive spinal cord injury in rats.

Authors:  Yerko A Berrocal; Vania W Almeida; Rocio Puentes; Eric P Knott; Jaclyn F Hechtman; Mary Garland; Damien D Pearse
Journal:  Pain Res Treat       Date:  2014-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.